Literature DB >> 27467497

Periprosthetic cortical bone remodeling in patients with an osseointegrated leg prosthesis.

Lisanne Maria Haket1, Johannes Paulus Maria Frölke2, Nico Verdonschot3,4, Pawel Krzysztof Tomaszewski3, Henk van de Meent1.   

Abstract

Qualitative studies have shown that the periprosthetic cortical bone may decrease in the first years after the implantation of an osseointegrated leg prosthesis (OILP) in patients with a transfemoral amputation. The resorption of periprosthetic cortical bone may endanger implant survival because of outbreak fractures and aseptic loosening. A decrease in periprosthetic bone quality may also lead to insufficient bone stock for potential revision surgery. This study quantified the periprosthetic bone changes and skeletal remineralization in 27 patients with an ILP (Integrated Leg Prosthesis)-type transfemoral OILP. Periprosthetic cortical thickness was analyzed from standard anteroposterior (AP) radiographs that were taken immediately postoperatively and at both 12 and 24 months post-implantation. The bone mineral density of the femoral hip neck on both sides was measured pre-operatively with Dual X-ray absorptiometry (DXA) and at 12 and 24 months post-implantation. Compared to that immediately post-operative, the periprosthetic cortical thickness increased significantly by 9.6% (p = 0.020) and 8.9% (p < 0.001) at 12 and 24 months, respectively. The change in bone mineral density of the hip neck on both sides was not significant. In contrast to previous observations, this study reports increased periprosthetic cortical thickness around the OILP implant in the first 2 years after implantation. These data indicate good prospects for implant survival and possibilities for revision surgery.
© 2016 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 35:1237-1241, 2017. © 2016 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.

Entities:  

Keywords:  amputation; bone remodeling; osseointegration; prosthesis

Mesh:

Year:  2016        PMID: 27467497     DOI: 10.1002/jor.23376

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  7 in total

Review 1.  [Transcutaneous osseointegrated prosthesis (TOP) after limb amputation : Status quo and perspectives].

Authors:  Christian Willy; Christian Krettek
Journal:  Unfallchirurg       Date:  2017-05       Impact factor: 1.000

2.  What Are the Risk Factors for Mechanical Failure and Loosening of a Transfemoral Osseointegrated Implant System in Patients with a Lower-limb Amputation?

Authors:  Jamal Mohamed; David Reetz; Henk van de Meent; Hendrik Schreuder; Jan Paul Frölke; Ruud Leijendekkers
Journal:  Clin Orthop Relat Res       Date:  2022-04-01       Impact factor: 4.755

Review 3.  A review of musculoskeletal adaptations in individuals following major lower-limb amputation.

Authors:  M G Finco; Suhhyun Kim; Wayne Ngo; Rachel A Menegaz
Journal:  J Musculoskelet Neuronal Interact       Date:  2022-06-01       Impact factor: 1.864

4.  Development of a Procedure for the Government Provision of Bone-Anchored Prosthesis Using Osseointegration in Australia.

Authors:  Laurent Frossard; Gregory Merlo; Tanya Quincey; Brendan Burkett; Debra Berg
Journal:  Pharmacoecon Open       Date:  2017-12

Review 5.  Osseointegrated prosthesis for patients with an amputation : Multidisciplinary team approach in the Netherlands.

Authors:  J P M Frölke; R A Leijendekkers; H van de Meent
Journal:  Unfallchirurg       Date:  2017-04       Impact factor: 1.000

6.  Three-year follow-up of changes of cortical bone thickness after implantation of Endo-Exo-Prosthesis (EEP) for transfemoral amputees.

Authors:  Marcus Örgel; Emmanouil Liodakis; Pratya Jaratjitwilai; Afif Harb; Nils Wirries; Mohamed Omar; Christian Krettek; Horst-Heinrich Aschoff
Journal:  J Orthop Surg Res       Date:  2020-05-04       Impact factor: 2.359

7.  Variation in bone response to the placement of percutaneous osseointegrated endoprostheses: A 24-month follow-up in sheep.

Authors:  Sujee Jeyapalina; James Peter Beck; Alex Drew; Roy D Bloebaum; Kent N Bachus
Journal:  PLoS One       Date:  2019-10-25       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.